Which of the following is NOT listed as a safe agent to administer in acute intermittent porphyria management?

Which of the following is NOT listed as a safe agent to administer in acute intermittent porphyria management?

• A. Ketamine
• B. Volatile anesthetics
• C. Zofran
• D. Beta blockers

Answer: (A)

Acute intermittent porphyria attacks are triggered by drugs that induce hepatic ALA synthase, boosting porphyrin precursor production and risking neurovisceral symptoms. In management, we choose agents with minimal or no induction of the heme pathway. Ketamine is not listed as a safe option because it can be porphyrinogenic; it may stimulate the pathway that leads to excess porphyrin precursors, so it should be avoided in acute porphyria management. Volatile anesthetics are considered safe in porphyria because they do not meaningfully induce ALA synthase and have a long track record of use without provoking attacks. Zofran (ondansetron) is also viewed as safe for porphyria patients when treating nausea. Beta blockers are generally regarded as safe options in this context, as they do not trigger porphyrin synthesis to a clinically significant degree. So the reason the first choice stands out is that it’s not on the list of drugs deemed safe for porphyria management, unlike the other options provided. Always consult current porphyria drug safety resources for specifics, but the principle remains: avoid drugs that upregulate the heme synthesis pathway.

Acute intermittent porphyria attacks are triggered by drugs that induce hepatic ALA synthase, boosting porphyrin precursor production and risking neurovisceral symptoms. In management, we choose agents with minimal or no induction of the heme pathway.

Ketamine is not listed as a safe option because it can be porphyrinogenic; it may stimulate the pathway that leads to excess porphyrin precursors, so it should be avoided in acute porphyria management.

Volatile anesthetics are considered safe in porphyria because they do not meaningfully induce ALA synthase and have a long track record of use without provoking attacks. Zofran (ondansetron) is also viewed as safe for porphyria patients when treating nausea. Beta blockers are generally regarded as safe options in this context, as they do not trigger porphyrin synthesis to a clinically significant degree.

So the reason the first choice stands out is that it’s not on the list of drugs deemed safe for porphyria management, unlike the other options provided. Always consult current porphyria drug safety resources for specifics, but the principle remains: avoid drugs that upregulate the heme synthesis pathway.